Tumour macrophages as potential targets of bisphosphonates.
about
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenProstate cancer and parasitism of the bone hematopoietic stem cell nicheImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerLive imaging and gene expression analysis in zebrafish identifies a link between neutrophils and epithelial to mesenchymal transitionCD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid.Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.Obesity, cholesterol metabolism, and breast cancer pathogenesisNew roads open up for implementing immunotherapy in mesothelioma.Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma.Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical studyMacrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphomaBiodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.Addressing the controversy: do bisphosphonates directly affect primary tumors?Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells.Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisationCan Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas--an immunohistochemical study.Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatmentCancer microenvironment and cancer vaccine.The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell nichesTumor-associated macrophages: unwitting accomplices in breast cancer malignancy.Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion.Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients.Bisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate!Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients.Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trialsBisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism.Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery SystemsThe invisible arm of immunity in common cancer chemoprevention agents.Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer.Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.Targeting tumor-infiltrating macrophages to combat cancer.Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.Design and Biological Evaluation of Delivery Systems Containing BisphosphonatesAnti-tumour strategies aiming to target tumour-associated macrophages.Clinical opportunities and challenges in targeting tumour dormancy.
P2860
Q26749972-EE8FE016-ABFE-4258-B261-498E4CA19094Q26996231-A142864D-201B-457A-98E6-C2ABAC7492E4Q26996829-F8D1775A-F8D2-4C49-A764-D09C967CBADDQ27330504-538CC996-8B44-45F3-8C96-7A6FC0048419Q33591592-215D744A-5554-422A-8131-B5513682A512Q33739204-C808B96E-EB4F-4180-AD6A-7A3673B4C826Q34035071-E21A7770-73D0-4A28-9C1A-9D4F2A3AB6F8Q34142500-C6FF34DF-83AD-45EA-BAC5-D2AA0AA0D5FCQ34204836-A28F6F18-9322-49D5-A132-ECEAA1D32883Q34331993-C348AA5D-B002-49A9-88C1-9A6DC6A8E2ADQ34458449-473E477D-0C76-4B3A-900E-28B04EA7582CQ34468743-67CD03D3-CA62-49F9-B30F-AF0C7EEF76DEQ34627838-1D32AAF6-8694-404F-81EC-58D66AF787C2Q34631566-A51C9A7D-43E6-4EB7-97CD-F592B5D98205Q34970986-F962A036-3877-4E4B-8369-20759D477049Q35008733-1CE98953-9B45-460D-A98F-282D82C22300Q35678372-FD0E1A37-71E7-4377-9F18-73F84DE5B865Q35750453-413745E3-3E92-41AF-A0C0-2E874E2FADA1Q35833077-A2CCDC98-923A-434B-91E0-CC9308A861FEQ35909590-DB6B343B-2488-434A-BE6E-F993E878C3D2Q35987443-89896B4A-43AF-453C-AAAF-49E01002B68BQ36284923-B426204E-48D4-4C3B-BB17-C664A91E535FQ36671015-28CB0BD1-23C0-4278-9DED-0993F56A002BQ36692838-2FC19A68-6C49-4BB0-8173-43829C4FAD7EQ36729107-A79C4DF8-CB55-4081-A261-AE2DE45E92BAQ36807447-137D880F-8D91-4BDA-835B-E2B560B32BB7Q36963360-94227DDF-BE54-4D29-A70E-3807D4360BEAQ36998185-19CF1274-430C-4437-BA41-C07CBC3B433AQ37055591-57B5D70E-348B-49A3-8AB6-900B4DF26939Q37087037-D9B53B75-4608-48B0-8DBD-B1DC7A81B32BQ37117425-822E2124-F722-4189-9A71-67C7214F62A7Q37172099-80965A0C-B5CD-4046-A3BC-504A597CAE20Q37316047-B0FC5D5B-5D19-4624-9331-B5487FBF3DC3Q37364878-3C67999C-CCA6-4CB1-92F9-4CB4C91ACA9AQ37401717-26E6DA54-149A-40DA-8E37-340F63B0FA96Q37585138-5DF20787-84C7-4BE1-BD3C-163B9DE2B4C8Q37694632-0F0C77A2-D224-4F29-A8E4-66ED1E977739Q37731222-6C0764B0-8A5B-4ADC-96B1-1E12B7287373Q38056746-DB1A1701-E885-4B74-98C3-1A11347C4C04Q38062792-A1B19C24-6104-4652-8CC7-70B717054BAE
P2860
Tumour macrophages as potential targets of bisphosphonates.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tumour macrophages as potential targets of bisphosphonates.
@ast
Tumour macrophages as potential targets of bisphosphonates.
@en
type
label
Tumour macrophages as potential targets of bisphosphonates.
@ast
Tumour macrophages as potential targets of bisphosphonates.
@en
prefLabel
Tumour macrophages as potential targets of bisphosphonates.
@ast
Tumour macrophages as potential targets of bisphosphonates.
@en
P2860
P921
P356
P1476
Tumour macrophages as potential targets of bisphosphonates
@en
P2093
Thea L Rogers
P2860
P2888
P356
10.1186/1479-5876-9-177
P50
P5008
P577
2011-10-17T00:00:00Z
P5875
P6179
1020137358